CARSGEN-B Rises 4.4% as Anticipated Loss for 2025 Set to Decrease by 85%
Stock Performance: CARSGEN-B (02171.HK) opened 4.43% higher at $16.5 with a pre-market trading volume of 10,500 shares, amounting to $173,200.
Financial Outlook: The company expects a net loss of no more than approximately RMB120 million for the year ending December 31, 2025, a significant reduction of at least 85% from RMB798 million in 2024.
Adjusted Loss: The adjusted net loss is anticipated to be around RMB95 million, compared to RMB789 million for the same period in 2024.
Short Selling Activity: The short selling for CARSGEN-B is reported at $1.89 million, with a ratio of 12.440%.
Trade with 70% Backtested Accuracy
Analyst Views on 02171
No data
About the author
<Midday Update> HSI Rises by 396 Points; HSTI Gains 69 Points; TENCENT Surges Over 5%; BABA Increases Over 3%; LINGBAOGOLD-100 and HUISHANG BANK Reach New Peaks
Market Performance: The Hang Seng Index (HSI) rose by 396 points (1.6%) to 25,804, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 69 points (1.4%) and 91 points (1.1%) respectively.
Top Gainers: Notable gainers included TENCENT (+5.7% to $545.5), BABA (+3% to $132.6), and CATL (+8.7% to $547), with significant short selling activity reported for these stocks.
Decliners: DEEPEXI TECH experienced a sharp decline of 18.6%, closing at $88.25, while other stocks like XIAOMI and MEITUAN also saw slight decreases.
Short Selling Trends: High short selling ratios were observed in several stocks, including XIAOMI (32.91%) and MEITUAN (34.52%), indicating investor caution or bearish sentiment in these companies.
CARSGEN-B Rises 4.4% as Anticipated Loss for 2025 Set to Decrease by 85%
Stock Performance: CARSGEN-B (02171.HK) opened 4.43% higher at $16.5 with a pre-market trading volume of 10,500 shares, amounting to $173,200.
Financial Outlook: The company expects a net loss of no more than approximately RMB120 million for the year ending December 31, 2025, a significant reduction of at least 85% from RMB798 million in 2024.
Adjusted Loss: The adjusted net loss is anticipated to be around RMB95 million, compared to RMB789 million for the same period in 2024.
Short Selling Activity: The short selling for CARSGEN-B is reported at $1.89 million, with a ratio of 12.440%.
<Research>UBS Identifies Chinese Stocks with Greatest Potential for FY26 Earnings Growth (Table)
UBS China Market Strategy Report: UBS has released a report highlighting Buy-rated Chinese stocks with significant potential for earnings growth by FY26, focusing on Hong Kong-listed and ADR-listed companies.
Highlighted Stocks: The report includes stocks such as INNOCARE, CARSGEN-B, ZAI LAB, AKESO, and CANSINOBIO, along with their recent performance and short selling data.
Short Selling Data: The report provides short selling figures for the listed stocks, indicating varying levels of short interest, with ZAI LAB and AKESO showing higher short selling ratios.
Related Market Insights: Additional context is provided by Soochow Securities, which lists the top 10 Hong Kong stocks with the highest net buys and sells by southbound funds in the previous week.
<Midday Update> HSI Rises by 396 Points; HSTI Gains 69 Points; TENCENT Surges Over 5%; BABA Increases Over 3%; LINGBAOGOLD-100 and HUISHANG BANK Reach New Peaks
Market Performance: The Hang Seng Index (HSI) rose by 396 points (1.6%) to 25,804, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 69 points (1.4%) and 91 points (1.1%) respectively.
Top Gainers: Notable gainers included TENCENT (+5.7% to $545.5), BABA (+3% to $132.6), and CATL (+8.7% to $547), with significant short selling activity reported for these stocks.
Decliners: DEEPEXI TECH experienced a sharp decline of 18.6%, closing at $88.25, while other stocks like XIAOMI and MEITUAN also saw slight decreases.
Short Selling Trends: High short selling ratios were observed in several stocks, including XIAOMI (32.91%) and MEITUAN (34.52%), indicating investor caution or bearish sentiment in these companies.
CARSGEN-B Rises 4.4% as Anticipated Loss for 2025 Set to Decrease by 85%
Stock Performance: CARSGEN-B (02171.HK) opened 4.43% higher at $16.5 with a pre-market trading volume of 10,500 shares, amounting to $173,200.
Financial Outlook: The company expects a net loss of no more than approximately RMB120 million for the year ending December 31, 2025, a significant reduction of at least 85% from RMB798 million in 2024.
Adjusted Loss: The adjusted net loss is anticipated to be around RMB95 million, compared to RMB789 million for the same period in 2024.
Short Selling Activity: The short selling for CARSGEN-B is reported at $1.89 million, with a ratio of 12.440%.
<Research>UBS Identifies Chinese Stocks with Greatest Potential for FY26 Earnings Growth (Table)
UBS China Market Strategy Report: UBS has released a report highlighting Buy-rated Chinese stocks with significant potential for earnings growth by FY26, focusing on Hong Kong-listed and ADR-listed companies.
Highlighted Stocks: The report includes stocks such as INNOCARE, CARSGEN-B, ZAI LAB, AKESO, and CANSINOBIO, along with their recent performance and short selling data.
Short Selling Data: The report provides short selling figures for the listed stocks, indicating varying levels of short interest, with ZAI LAB and AKESO showing higher short selling ratios.
Related Market Insights: Additional context is provided by Soochow Securities, which lists the top 10 Hong Kong stocks with the highest net buys and sells by southbound funds in the previous week.
